SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

Must watch video: http://www.youtube.com/watch?feature=endscreen&NR=1&v=KcWA7v_cikw

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
fouraces Member Profile
 
Followed By 54
Posts 6,783
Boards Moderated 0
Alias Born 06/25/10
160x600 placeholder
Advertisement
AMARANTUS BIOSCIENCE - BUILDING UP THERAPEUTICS ASSETS "InvestorsHub NewsWire" - 7/28/2015 1:15:01 AM
Amarantus Diagnostics Establishes Strategic Advisory Committee "GlobeNewswire Inc." - 7/27/2015 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2015 4:16:56 PM
Amarantus Diagnostics Meets Primary and Secondary Endpoints in Blinded, Multi-Center LP-002 Clinical Study for LymPro(R) Bloo... "GlobeNewswire Inc." - 7/22/2015 10:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/21/2015 5:02:26 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/20/2015 5:13:21 PM
Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced D... "GlobeNewswire Inc." - 7/20/2015 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/16/2015 5:04:45 PM
Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns "GlobeNewswire Inc." - 7/15/2015 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/15/2015 7:01:49 AM
Amarantus to Commence Trading on the OTCQX Marketplace Under Existing Ticker Symbol AMBS "GlobeNewswire Inc." - 7/13/2015 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/13/2015 6:01:27 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2015 5:05:22 PM
Amarantus Announces Issuance of United States Patent No. 9,066,903 Covering Proprietary Methods of Administration of Eltopraz... "GlobeNewswire Inc." - 6/30/2015 8:35:00 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 6/23/2015 4:22:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/15/2015 4:06:38 PM
Amarantus Announces Presentation of Eltoprazine Phase 1/2a Clinical Data at the 19th International Congress of Parkinson's Di... "GlobeNewswire Inc." - 6/15/2015 7:05:00 AM
Amarantus to Present at the BIO International Convention "GlobeNewswire Inc." - 6/10/2015 8:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2015 5:17:35 PM
Amarantus Completes Capital Restructuring in Preparation for National Exchange Listing "GlobeNewswire Inc." - 6/9/2015 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2015 12:08:08 PM
Amarantus Diagnostics Announces Acceptance of Two Late-Breaking Abstracts on LymPro Test(R) Data at the 2015 Alzheimer's Asso... "GlobeNewswire Inc." - 6/9/2015 10:58:03 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/5/2015 2:15:00 PM
Amarantus Opens First Clinical Trial Site and Commences Patient Enrollment for Lead Product Candidate Eltoprazine's Phase 2b ... "GlobeNewswire Inc." - 6/5/2015 7:35:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist